循環器・腎臓・代謝疾患におけるフィネレノンの人体測定,心血管的結果,および治療効果: 3 つのグローバル試験の参加者レベルの分析
John W Ostrominski1, Josephine Harrington2, Brian L Claggett1
1Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Journal of the American College of Cardiology
|September 2, 2025
まとめ
肥満は,心血管,腎臓,代謝疾患を有する患者の心血管リスクを大幅に増加させる. 腹部肥満をBMIと共に測定することでリスク評価が改善され,フィネレノンはすべての肥満レベルの患者にとって有益です.
科学分野:
- 心臓病科
- 代謝 疾患
- 腎臓科
背景:
- 肥満は心臓血管,腎臓,代謝 (CKM) 疾患の重要な要因です.
- CKM患者における様々な肥満測定値と心血管のアウトカムとの関連については,さらなる調査が必要である.
研究 の 目的:
- 肥満の異なる人体測定法に基づいて,心臓血管のアウトカムとフィネレノンの治療効果を分析する.
- 体質指数 (BMI),腰周 (WC),腰高比 (WHtR),腰比 (WHR) が心血管疾患に関連しているかを調べる.
主な方法:
- FIDELIO-DKD,FIGARO-DKD,およびFINEARTS-HF試験の統合した分析.
- 多変数調整のコックス比例リスクとポアソン回帰を用いて結果を評価した.
- 肥満の様々な指標で,心臓血管のアウトカムとフィネレノンの有効性を調べました.
主要な成果:
- 高いBMI,WC,WHtR,およびWHRは,死亡または心不全の入院を含む心血管疾患の増加と関連していました.
- BMIとWHtRの上昇は,いずれかの測定値単独よりも高いリスクを示した.
- フィネレノンは,BMIやWHtRに関係なく,一貫した心血管上の利点を示し,より高い肥満のグループでは絶対的な利点がより大きい.
結論:
- 体重指数 (BMI) と並行して腹部肥満の測定値 (WC,WHtR,WHR) を評価することで,CKM患者における肥満の特定とリスクの階層化が改善されます.
- フィネレノンは,多種多様な肥満症候群において,有害な心血管疾患を効果的に軽減します.
関連する概念動画
01:17Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:11Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152
01:24Serum Studies: Renal Function Tests
43
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
43
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60